Samil Pharmaceutical Co.,Ltd (000520.KS) has a MoatMap StockRank of 14/100 based on Quality (25/100), Value (45/100), and Momentum (33/100) factor scores. The current signal is STRONG SELL. Samil Pharmaceutical Co., Ltd., a South Korean healthcare company, lacks a direct, strong, and unpriced macro tailwind. As an EM healthcare company, it faces general risks from 'Dollar Dominance, EM Strain' and typically struggles to meet the quality compounder criteria of asset-lightness, high ROIC, and durable moats required for a concentrated fund.